Skip to main content

Sales of Alnylam's first drug beat expectations in final quarter of 2018

The announcement commanded investor's attention to kick off the weeklong JP Morgan Healthcare conference.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.